Puma Biotech: Q1 Earnings Snapshot

13h ago, source: The Washington Post

LOS ANGELES — LOS ANGELES — Puma Biotechnology Inc. (PBYI) on Thursday reported a loss of $4.8 million in its first quarter. On a per-share basis, the Los Angeles-based company said it had a loss of ...

Puma Biotechnology is about to announce its earnings — here's what Wall Street expects

1d ago, source:

Puma Biotechnology will report latest earnings.Analysts expect Puma Biotechnology will release losses per share of $0.217.Go here to ...

Puma Biotechnology Inc PBYI

2d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Puma Biotechnology (NASDAQ: PBYI)

6d ago, source: The Motley Fool

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that ...

Puma Biotechnology Inc.

3d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

PBYI Puma Biotechnology, Inc.

1mon ago, source: Seeking Alpha

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company ...